Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli (2005)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2004.11.026
- Assunto: MICROBIOLOGIA
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2005
- Source:
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
LASARO, M. O. et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, v. 23, p. 2430-2438, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2004.11.026. Acesso em: 13 mar. 2026. -
APA
Lasaro, M. O., Luiz, W. B., Sbrogio-Almeida, M. E., & Ferreira, L. C. de S. (2005). Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine, 23, 2430-2438. doi:10.1016/j.vaccine.2004.11.026 -
NLM
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026 -
Vancouver
Lasaro MO, Luiz WB, Sbrogio-Almeida ME, Ferreira LC de S. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli [Internet]. Vaccine. 2005 ; 23 2430-2438.[citado 2026 mar. 13 ] Available from: https://doi.org/10.1016/j.vaccine.2004.11.026 - Evaluation of experimental conditions for quantification of LT produced by human derived enterotoxigenic Escherichia coli strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains based on intimin expression by recombinant Bacillus subtilis strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains
- Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules
- Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
- Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells
- Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors
- Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
- Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
- Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
